233 related articles for article (PubMed ID: 8853395)
21. Effects of the glucocorticoid II receptor antagonist mifepristone on hypertension in the obese Zucker rat.
Clapham JC; Turner NC
J Pharmacol Exp Ther; 1997 Sep; 282(3):1503-8. PubMed ID: 9316865
[TBL] [Abstract][Full Text] [Related]
22. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
[TBL] [Abstract][Full Text] [Related]
23. Long-term oral administration of dehydroepiandrosterone has different effects on energy intake of young lean and obese male Zucker rats when compared to controls of similar metabolic body size.
Richards RJ; Porter JR; Svec F
Diabetes Obes Metab; 1999 Jul; 1(4):233-9. PubMed ID: 11228759
[TBL] [Abstract][Full Text] [Related]
24. The glucocorticoid antagonist mifepristone reveals abnormal regulation of the adrenocortical system in obese Zucker rats.
Pesonen U; Koulu M; Heikinheimo O; Huupponen R
J Endocrinol; 1992 Mar; 132(3):425-31. PubMed ID: 1564428
[TBL] [Abstract][Full Text] [Related]
25. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats.
Meereis-Schwanke K; Klonowski-Stumpe H; Herberg L; Niederau C
Peptides; 1998; 19(2):291-9. PubMed ID: 9493861
[TBL] [Abstract][Full Text] [Related]
27. Abnormal polyunsaturated lipid metabolism in the obese Zucker rat, with partial metabolic correction by gamma-linolenic acid administration.
Phinney SD; Tang AB; Thurmond DC; Nakamura MT; Stern JS
Metabolism; 1993 Sep; 42(9):1127-40. PubMed ID: 8412765
[TBL] [Abstract][Full Text] [Related]
28. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin.
Oana F; Takeda H; Hayakawa K; Matsuzawa A; Akahane S; Isaji M; Akahane M
Metabolism; 2005 Aug; 54(8):995-1001. PubMed ID: 16092047
[TBL] [Abstract][Full Text] [Related]
29. Different responsiveness in body weight and hepatic 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type 1 mrna to 11beta-HSD inhibition by glycyrrhetinic acid treatment in obese and lean zucker rats.
Li RS; Nakagawa Y; Nakanishi T; Fujisawa Y; Ohzeki T
Metabolism; 2004 May; 53(5):600-6. PubMed ID: 15131764
[TBL] [Abstract][Full Text] [Related]
30. Effects of the glucocorticoid agonist, RU28362, and the antagonist RU486 on lung phosphatidylcholine and antioxidant enzyme development in the genetically obese Zucker rat.
Langley SC; Rickett GW; Hunt A; Kelly FJ; Postle AD; York DA
Biochem Pharmacol; 1993 Feb; 45(3):543-51. PubMed ID: 8442753
[TBL] [Abstract][Full Text] [Related]
31. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats.
Livingstone DE; Jones GC; Smith K; Jamieson PM; Andrew R; Kenyon CJ; Walker BR
Endocrinology; 2000 Feb; 141(2):560-3. PubMed ID: 10650936
[TBL] [Abstract][Full Text] [Related]
32. Effect of phenoxybenzamine on development of adipose tissue in lean and obese Zucker rats.
Comai K; Sullivan AC
Am J Physiol; 1982 Nov; 243(5):E398-406. PubMed ID: 7137343
[TBL] [Abstract][Full Text] [Related]
33. Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats.
Doyon C; Denis RG; Baraboi ED; Samson P; Lalonde J; Deshaies Y; Richard D
Diabetes; 2006 Dec; 55(12):3403-10. PubMed ID: 17130486
[TBL] [Abstract][Full Text] [Related]
34. Serotonergic activity is depressed in the ventromedial hypothalamic nucleus of 12-day-old obese Zucker rats.
Routh VH; Stern JS; Horwitz BA
Am J Physiol; 1994 Sep; 267(3 Pt 2):R712-9. PubMed ID: 7522410
[TBL] [Abstract][Full Text] [Related]
35. Decreased central and peripheral catecholaminergic activation in obese Zucker rats.
Pacak K; McCarty R; Palkovits M; Cizza G; Kopin IJ; Goldstein DS; Chrousos GP
Endocrinology; 1995 Oct; 136(10):4360-7. PubMed ID: 7664655
[TBL] [Abstract][Full Text] [Related]
36. Effect of somatotropin and feed restriction on body composition and adipose metabolism in obese Zucker rats.
Azain MJ; Hausman DB; Kasser TR; Martin RJ
Am J Physiol; 1995 Jul; 269(1 Pt 1):E137-44. PubMed ID: 7631768
[TBL] [Abstract][Full Text] [Related]
37. Blood flow to brown fat in lean and obese adrenalectomized Zucker rats.
Wickler SJ; Horwitz BA; Stern JS
Am J Physiol; 1986 Nov; 251(5 Pt 2):R851-8. PubMed ID: 3777213
[TBL] [Abstract][Full Text] [Related]
38. Mifepristone: treatment of Cushing's syndrome.
Sartor O; Cutler GB
Clin Obstet Gynecol; 1996 Jun; 39(2):506-10. PubMed ID: 8734015
[TBL] [Abstract][Full Text] [Related]
39. Effects of intracerebroventricular leptin administration on feeding and sexual behaviors in lean and obese female Zucker rats.
Fox AS; Olster DH
Horm Behav; 2000 Jun; 37(4):377-87. PubMed ID: 10860681
[TBL] [Abstract][Full Text] [Related]
40. The effect of DHEA given chronically to Zucker rats.
Svec F; Hilton CW; Wright B; Browne E; Porter JR
Proc Soc Exp Biol Med; 1995 May; 209(1):92-7. PubMed ID: 7536942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
